Papers using
CPT I
antibodies
The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathwaysKong Ling-Dong et al., In Evidence-based Complementary and Alternative Medicine : eCAM, 2007
... USA), ABCG2 by Cell Signaling Technology (Boston, MA, USA), OCTN2 by Abcam (Cambridge, MA, USA), CPT1 by Bioss Biotech (Beijing, P ...
Papers on
CPT I
MicroRNAs regulating lipid metabolism in atherogenesis.Moore et al., New York City, United States. In Thromb Haemost, Apr 2012
By repressing a variety of genes involved in cholesterol export and fatty acid oxidation, including ABCA1, CROT, CPT1, HADHB and PRKAA1, miR-33a/b act in concert with their host genes to boost cellular sterol levels.
A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency.Vamecq et al., Lille, France. In Jimd Rep, 2011
In early childhood, the patient developed a life-threatening episode (hypoketotic hypoglycemia, liver cytolysis, and hepatomegaly) evocative of a mitochondrial fatty acid oxidation disorder, and presented deficient fibroblast carnitine palmitoyltransferase 1 (CPT1) activity and homozygosity for the c.1783 C > T nucleotide substitution on exon 15 of CPT1A (p.R595W mutant).
Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.Vidal-Puig et al., A Coruña, Spain. In Cell Metab, 2008
Here, we use pharmacological and genetic approaches to demonstrate that the physiological orexigenic response to ghrelin involves specific inhibition of fatty acid biosynthesis induced by AMP-activated protein kinase (AMPK) resulting in decreased hypothalamic levels of malonyl-CoA and increased carnitine palmitoyltransferase 1 (CPT1) activity.